Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Results 1 - 20 of 422 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar Rodmancometh (< 20) Submitted: 8/4/2015 1:04:33 AM : Outperform Start Price: $118.77 GILD Score: +0.16

...

Recs

0
Member Avatar mcsprof (55.02) Submitted: 7/26/2015 10:19:27 PM : Outperform Start Price: $112.63 GILD Score: +4.39

Gilead is a well managed pharmaceutical company with several drugs with good prospects in the pipeline.

Recs

0
Member Avatar healthcarevalue (97.55) Submitted: 7/25/2015 9:23:48 PM : Outperform Start Price: $112.63 GILD Score: +4.39

Gilead Sciences Inc. (GILD) - debt/equity ratio of 0.69. Return on Invested Capital (ROIC) last TTM of 55.41 is quite impressive to say the least. TTM price/earnings ratio of 12.9 shows stock is priced cheaply compared to its industry at present. Lots of great niche healthcare products, as well as good strategic partnerships with other medical companies.

Recs

0
Member Avatar Orthonormal (89.37) Submitted: 7/25/2015 12:29:42 AM : Outperform Start Price: $112.63 GILD Score: +4.39

Magic Formula 12/12/2014

Recs

0
Member Avatar dmick9 (34.74) Submitted: 7/24/2015 10:45:16 AM : Outperform Start Price: $114.86 GILD Score: +3.54

Strong sales and growth in the HIV and hepatitis C markets along with a growing cash balance give Gilead both a strong case for both organic growth and growth through acquisitions and/or share buybacks & dividend hikes.

Recs

0
Member Avatar bullishsky (< 20) Submitted: 7/16/2015 11:01:12 AM : Outperform Start Price: $118.78 GILD Score: +1.28

Pharma success with great opportunity

Recs

0
Member Avatar xdmarz (< 20) Submitted: 7/15/2015 8:01:52 PM : Outperform Start Price: $118.33 GILD Score: +1.66

Pharmacuticals, Yeah!!

Recs

0
Member Avatar wstanislaw (42.52) Submitted: 7/10/2015 5:59:12 PM : Outperform Start Price: $114.66 GILD Score: +3.63

Eps of $8.80 at 13% growth easily supports the current share price. Potentials for this company are enormous with their hepatitis, hiv and cancer treatments, plus the global markets are opening for them as well.

Recs

1
Member Avatar TMFCheesehead (63.53) Submitted: 7/10/2015 4:19:54 PM : Outperform Start Price: $115.00 GILD Score: +3.21

It's hard to argue against a company with this valuation and such a huge pile of cash.

Recs

0
Member Avatar bcurtis9944 (52.53) Submitted: 7/7/2015 11:15:33 PM : Outperform Start Price: $114.25 GILD Score: +3.42

one third the p/e of its direct competitor ABBV.
Japan just approved the new hepatitis drug,
Japan has the highest rates of liver diseases

Recs

0
Member Avatar haledrich (20.45) Submitted: 6/24/2015 11:35:49 PM : Outperform Start Price: $122.48 GILD Score: -2.10

great pipeline

Recs

0
Member Avatar DrGoldin (99.71) Submitted: 6/24/2015 11:00:21 AM : Outperform Start Price: $49.32 GILD Score: +109.59

With the share price at an all-time high and most of the earnings growth behind us, I'm trimming my real position in Gilead (cha-ching!), but in CAPS I can't afford to do that, because the peculiar rules of the game make it advantageous to keep the position open when you have a low start price.

(My favorite big-boy biotech right now is Celgene. It's my biggest single holding.)

Recs

0
Member Avatar clangmead (26.29) Submitted: 6/23/2015 7:50:36 AM : Outperform Start Price: $121.82 GILD Score: -1.09

posh

Recs

0
Member Avatar redhead77 (< 20) Submitted: 6/15/2015 1:48:35 PM : Outperform Start Price: $117.97 GILD Score: +0.57

Positivie looking pipeline of important drugs, especially blood cancers. Also an emotional vote from me as I've seen what it does in my own family.

Recs

0
Member Avatar 2trpop (92.54) Submitted: 6/15/2015 9:37:59 AM : Outperform Start Price: $101.58 GILD Score: +14.54

Dividend Payout

POSTED AT 6/12/2015 10:38:47 AM

The stock GILD has paid out a dividend of $0.43000. The starting price for your pick has been adjusted to reflect the value of this dividend payout.

Recs

0
Member Avatar dscrugham (< 20) Submitted: 6/9/2015 12:39:14 PM : Outperform Start Price: $114.51 GILD Score: +3.53

It has a great year ahead & has the BEST P/E!

Recs

0
Member Avatar NHWeston102 (46.63) Submitted: 6/5/2015 4:23:37 PM : Outperform Start Price: $113.55 GILD Score: +4.84

The pipeline is gushing.

Recs

0
Member Avatar ruinas (60.00) Submitted: 6/2/2015 7:30:14 PM : Underperform Start Price: $113.86 GILD Score: -5.67

Biotech stocks Are overpriced and should drop in price.

Recs

0
Member Avatar Treborn822 (81.16) Submitted: 5/30/2015 2:09:51 PM : Outperform Start Price: $112.76 GILD Score: +6.65

Great drugs in the pipeline

Recs

0
Member Avatar chris2ffer (62.19) Submitted: 5/26/2015 10:01:58 PM : Outperform Start Price: $109.94 GILD Score: +9.03

Alot of great drugs on the way

Featured Broker Partners


Advertisement